Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic dermatitis

J M Hanifin

    Journal of the American Academy of Dermatology
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Atopic dermatitis involves immune system dysregulation and altered responses to stimuli. Abnormal cyclic adenosine monophosphate (cAMP) metabolism may be key to understanding and treating this chronic inflammatory skin condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pioneers in Dermatology and Venereology: an interview with Jon Hanifin, M.D.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality-of-life measure for adult atopic dermatitis.

    The British journal of dermatology·2018
    Same author

    Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis.

    The British journal of dermatology·2017
    Same author

    What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study.

    The British journal of dermatology·2015
    Same author

    Inadequate response to ustekinumab in atopic dermatitis - a report of two patients.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2014
    Same author

    Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).

    The British journal of dermatology·2014
    Same journal

    Localized radiation therapy provides more durable disease control than topical steroids in stage IA mycosis fungoides.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Atypical fibroxanthoma, pleomorphic dermal sarcoma, and undifferentiated sarcoma: Updates on diagnosis, management, and surveillance.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Response to Li et al., "Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'".

    Journal of the American Academy of Dermatology·2026
    Same journal

    Treatment Utilization Patterns in Cutaneous Lupus Erythematosus: A Single-Center Retrospective Analysis.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

    Journal of the American Academy of Dermatology·2026
    See all related articles

    Area of Science:

    • Immunology
    • Dermatology
    • Pharmacology

    Background:

    • Atopic dermatitis is a chronic inflammatory skin disease characterized by immune dysregulation.
    • Elevated serum IgE and cellular immune defects are observed during disease flares and remissions.
    • Altered responsiveness to cholinergic and adrenergic agents suggests issues with cyclic nucleotide regulation.

    Purpose of the Study:

    • To explore the role of cyclic nucleotide regulation in atopic dermatitis.
    • To investigate potential links between phosphodiesterase activity and disease pathogenesis.

    Main Methods:

    • The study focuses on recent observations regarding cyclic adenosine monophosphate (cAMP)-phosphodiesterase activity.
    • Analysis of immune and pharmacologic responses in patients with atopic dermatitis.

    Related Experiment Videos

    Main Results:

    • Abnormal cyclic adenosine monophosphate (cAMP)-phosphodiesterase activity has been observed in atopic dermatitis.
    • These findings suggest a potential mechanism for altered cellular responsiveness.

    Conclusions:

    • Abnormalities in cyclic adenosine monophosphate (cAMP)-phosphodiesterase activity may offer new insights into atopic dermatitis pathogenesis.
    • This could lead to novel therapeutic strategies for managing the disease.